Enovis (ENOV) Q4 Earnings and Revenues Surpass Estimates

Group 1 - Enovis reported quarterly earnings of $0.98 per share, exceeding the Zacks Consensus Estimate of $0.92 per share, and up from $0.79 per share a year ago, representing an earnings surprise of 6.52% [1] - The company posted revenues of $560.98 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 0.84%, and an increase from $455.02 million year-over-year [2] - Enovis has surpassed consensus EPS estimates three times over the last four quarters, indicating a positive trend in earnings performance [2] Group 2 - The stock has underperformed the market, losing about 4.1% since the beginning of the year compared to the S&P 500's gain of 1.3% [3] - The current consensus EPS estimate for the upcoming quarter is $0.68 on revenues of $552.17 million, and for the current fiscal year, it is $3.19 on revenues of $2.23 billion [7] - The Zacks Industry Rank places Medical Info Systems in the bottom 49% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]